Endoscopy 2006; 38(3): 254-259
DOI: 10.1055/s-2005-921069
Original Article
© Georg Thieme Verlag KG Stuttgart · New York

Multiple Stenting of Refractory Pancreatic Duct Strictures in Severe Chronic Pancreatitis: Long-term Results

G.  Costamagna1 , M.  Bulajic1 , A.  Tringali1 , M.  Pandolfi2 , A.  Gabbrielli2 , C.  Spada1 , L.  Petruzziello1 , P.  Familiari1 , M.  Mutignani1
  • 1Digestive Endoscopy Unit, Catholic University, Rome, Italy
  • 2Department of Gastroenterology, Campus Biomedico University, Rome, Italy
Further Information

Publication History

Submitted 21 April 2005

Accepted after revision 5 July 2005

Publication Date:
10 March 2006 (online)

Background and Study Aims: Dominant pancreatic duct strictures located in the head of the pancreas in patients with severe chronic pancreatitis are often managed by endoscopic placement of a single plastic stent. Patients with refractory strictures after prolonged stenting require repeated stent replacement or surgical pancreaticojejunostomy. Placement of multiple plastic stents has proved effective in managing postoperative biliary strictures. The aim of this study was to investigate the feasibility, efficacy, and long-term results of multiple stenting of refractory pancreatic strictures in severe chronic pancreatitis.
Patients and Methods: 19 patients with severe chronic pancreatitis (16 men, three women; mean age 45 years) and with a single pancreatic stent through a refractory dominant stricture in the pancreatic head underwent the following protocol: (i) removal of the single pancreatic stent; (ii) balloon dilation of the stricture; (iii) insertion of the maximum number of stents allowed by the stricture tightness and the pancreatic duct diameter; and (iv) removal of stents after 6 to 12 months.
Results: The median number of stents placed through the major or minor papilla was 3, with diameters ranging from 8.5 to 11.5 Fr and length from 4 to 7 cm. Only one patient (5.5 %) had persistent stricture after multiple stenting. During a mean follow-up of 38 months after removal, 84 % of patients were asymptomatic, and 10.5 % had symptomatic stricture recurrence. No major complications were recorded.
Conclusion: Endoscopic multiple stenting of dominant pancreatic duct strictures in chronic pancreatitis is a feasible and safe technique. Multiple pancreatic stenting is promising in obtaining persistent stricture dilation on long-term follow-up in the setting of severe chronic pancreatitis.

References

  • 1 Eleftheriadis N, Dinu F, Delhaye M. et al . Long-term outcome after pancreatic stenting in severe chronic pancreatitis.  Endoscopy. 2005;  37 223-230
  • 2 Huibregtse K, Schneider B, Vrij A A, Tytgat G. Endoscopic pancreatic drainage in chronic pancreatitis.  Gastrointest Endosc. 1988;  34 9-15
  • 3 McCarthy J, Geenen J E, Hogan W J. Preliminary experience with endoscopic stent placement in benign pancreatic diseases.  Gastrointest Endosc. 1988;  34 16-18
  • 4 Kozarek R A, Patterson D J, Ball T J, Traverso L W. Endoscopic placement of pancreatic stents and drains in the management of pancreatitis.  Ann Surg. 1989;  209 261-266
  • 5 Cremer M, Deviere J, Delhaye M. et al . Stenting in severe chronic pancreatitis: results of medium-term follow-up in seventy six patients.  Endoscopy. 1991;  23 171-176
  • 6 Binmoeller K F, Jue P, Siefert H, Nam W C, Izbicki J, Soehendra N. Endoscopic pancreatic stent drainage in chronic pancreatitis and a dominant stricture: long term results.  Endoscopy. 1995;  27 638-644
  • 7 Ponchon T, Bory R M, Hedelius F. et al . Endoscopic stenting for pain relief in chronic pancreatitis: results of a standardized protocol.  Gastrointest Endosc. 1995;  42 452-456
  • 8 Smits M E, Badiga S M, Rauws E AJ. et al . Long-term results of pancreatic stents in chronic pancreatitis.  Gastrointest Endosc. 1995;  42 461-467
  • 9 Eisendrath P, Deviere J. Expandable metal stents for benign pancreatic duct obstruction.  Gastrointest Endosc Clin N Am. 1999;  9 547-554
  • 10 Costamagna G, Pandolfi M, Mutignani M. et al . Long-term results of endoscopic management of postoperative bile duct strictures with increasing numbers of stents.  Gastrointest Endosc. 2001;  54 162-168
  • 11 Kozarek R A. Pancreatic stents can induce ductal changes consistent with chronic pancreatitis.  Gastrointest Endosc. 1990;  36 93-95
  • 12 Sherman S, Hawes R, Savides T. et al . Stent induced pancreatic ductal and parenchymal changes: correlation of endoscopic ultrasound with ERCP.  Gastrointest Endosc. 1996;  44 276-282
  • 13 Gulliver D, Edmunds S, Baker M. et al . Stent placement for benign pancreatic diseases: correlation between ERCP findings and clinical response.  AJR Am J Roentgenol. 1992;  159 751-755
  • 14 Ziebert J J, DiSario J A. Dilation of refractory pancreatic duct strictures: the turn of the screw.  Gastrointest Endosc. 1999;  49 632-635
  • 15 Hammarstrom L E, Stridbeck H, Ihse I. Endoscopic drainage in benign pancreatic disease: immediate and medium term outcome.  Eur J Surg. 1997;  163 577-589
  • 16 Rosch T, Daniel S, Scholz M. et al . Endoscopic treatment of chronic pancreatitis: a multicenter study of 1000 patients with long-term follow-up.  Endoscopy. 2002;  34 765-771
  • 17 Dite P, Ruzicka M, Zboril V, Novotny I. A prospective, randomized trial comparing endoscopic and surgical therapy for chronic pancreatitis.  Endoscopy. 2003;  35 553-558
  • 18 Cahen D L, Gouma D J, Nio Y. et al . Endoscopic versus surgical drainage of the pancreatic duct in chronic pancreatitis: a prospective randomized trial [abstract].  Gastrointest Endosc. 2005;  61 AB99

G. Costamagna, M. D.

Director Digestive Endoscopy Unit, Università Cattolica del Sacro Cuore ·

A. Gemelli University Hospital · Largo A. Gemelli 8 · 00168 Rome · Italy

Fax: +39-06-30156581 ·

Email: gcostamagna@rm.unicatt.it

    >